Treatment of Primary Sclerosing Cholangitis with Osteoporosis (Bone Mineral Density T-score ≤ −2.5)

Reduced bone density is a recognised complication of Primary sclerosing cholangitis. When bone mineral density reaches a T-score of −2.5 or below, management must address the osteoporosis directly alongside the underlying condition.

Clinical scenario

Patient with Primary sclerosing cholangitis presenting with confirmed osteoporosis (bone mineral density T-score ≤ −2.5), a normal serum vitamin D level, and no esophageal varices.

Management approach

This protocol incorporates vitamin D and calcium supplementation together with a bone-protective pharmacological agent selected based on the clinical picture. The complete agent selection, route considerations, and clinical guidance are detailed in the full protocol.

Full regimen, dosing, and clinical parameters available in the structured protocol below ↓

Instant Access to Structured Evidence-Based Regimens

References

Osteoporosis: Characterized by bone mineral density T-score standard deviation ≤−2.5.

In patients with PSC with normal serum vitamin D levels who have osteopenia or osteoporosis, vitamin D (2000 IU/day) and calcium (1–1.5 g/day) supplementation should be administered.

Patients with osteoporosis should additionally receive bisphosphonate therapy orally or parenterally (in the presence of esophageal varices).

DOI: 10.1002/hep.32771

View source ↗